Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR

Por Panousis, C, Rayzman, V M, Johns, T G, Renner, C, Liu, Z, Cartwright, G, Lee, F-T, Wang, D, Gan, H, Cao, D, Kypridis, A, Smyth, F E, Brechbiel, M W, Burgess, A W, Old, L J, Scott, A M
Publicado em 2005